Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) | MicrobiomeTrials← Back to trialsNCT06721871
Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2025-05-01Est. Completion: 2026-12
Enrollment target: 6 participants Locations- Boston Children's Hospital, Boston, Massachusetts, United States
- UOS Gastroenterolgia e Riabilitazione nutrizionale Piazza Sant' Onofrio 4, Rome, Italy
- Al Jalila Children's Hospital, Dubai, United Arab Emirates
Other microbiome trials you might be interested in
CholestasisPrematurityGastroschisisIntestinal AtresiaNecrotizing Enterocolitis
Hypothesis to be Tested:
Since the first description of intravenous alimentation over half a century ago, parenteral nu…
Miami, United StatesCompleted Jun 2010